It has been mentioned that the IK6 isoforms of IKZF1 and DNA-binding domain point mutations in mouse models of BCR-ABL1-positive leukemia resulted in dasatinib resistance, cellular mislocalization, and the induction of stem cells [18]. The gene discussed is IKZF1; the disease is leukemia.